DSpace Repository

Anti-inflammatory and cytotoxic agents from Xylaria sp. SWUF09-62 fungus

Show simple item record

dc.contributor.author Patjana T.
dc.contributor.author Jantaharn P.
dc.contributor.author Katrun P.
dc.contributor.author Mongkolthanaruk W.
dc.contributor.author Suwannasai N.
dc.contributor.author Senawong T.
dc.contributor.author Tontapha S.
dc.contributor.author Amornkitbumrung V.
dc.contributor.author McCloskey S.
dc.date.accessioned 2022-03-10T13:17:26Z
dc.date.available 2022-03-10T13:17:26Z
dc.date.issued 2021
dc.identifier.issn 14786419
dc.identifier.other 2-s2.0-85071024282
dc.identifier.uri https://ir.swu.ac.th/jspui/handle/123456789/17539
dc.identifier.uri https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071024282&doi=10.1080%2f14786419.2019.1652292&partnerID=40&md5=38a2f447c8d906b70394b5545a002d26
dc.description.abstract The ongoing search for anti-cancer agents from microorganisms led to the isolation of four new compounds including 6-ethyl-8-hydroxy-4H-chromen-4-one (1), 6-ethyl-7,8-dihydroxy-4H-chromen-4-one (2), (3S)-3,4-dihydro-8-hydroxy-7-methoxy-3-methylisocoumarin (3) and (3S)-3,4-dihydro-5,7,8-trihydroxy-3-methylisocoumarin (4), together with eleven known compounds (5–15) from Xylaria sp. SWUF09-62 fungus. The chemical structures were deduced from IR, 1D and 2D NMR, and MS data. The absolute configurations of 3 and 4 were determined by ECD experiment. Compounds 2 and 4 indicated possible chemo-prevention and chemo-therapeutic properties, exhibited anti-inflammatory properties by reducing nitric oxide production in LPS-stimulated RAW264.7 cells (IC50 = 1.57 ± 0.25 and 3.02 ± 0.27 μg/mL) and cytotoxicity against HT29 cells (IC50 = 16.46 ± 0.48 and 97.78 ± 7.14 μg/mL). © 2019 Informa UK Limited, trading as Taylor & Francis Group.
dc.subject 3,4 dihydro 5,7,8 trihydroxy 3 methylisocoumarin
dc.subject 3,4 dihydro 8 hydroxy 7 methoxy 3 methylisocoumarin
dc.subject 6 ethyl 7,8 dihydroxy 4h chromen 4 one
dc.subject 6 ethyl 8 hydroxy 4h chromen 4 one
dc.subject antiinflammatory agent
dc.subject cytotoxic agent
dc.subject diclofenac
dc.subject nitric oxide
dc.subject unclassified drug
dc.subject antiinflammatory agent
dc.subject antineoplastic agent
dc.subject biological product
dc.subject lipopolysaccharide
dc.subject antiinflammatory activity
dc.subject Article
dc.subject cancer cell
dc.subject carbon nuclear magnetic resonance
dc.subject cell viability
dc.subject chemical structure
dc.subject chemoprophylaxis
dc.subject controlled study
dc.subject cytotoxicity
dc.subject fungus
dc.subject IC50
dc.subject infrared spectroscopy
dc.subject macrophage
dc.subject mass spectrometry
dc.subject MTT assay
dc.subject nonhuman
dc.subject nuclear magnetic resonance
dc.subject Xylariales
dc.subject animal
dc.subject chemistry
dc.subject HCT 116 cell line
dc.subject HT-29 cell line
dc.subject human
dc.subject metabolism
dc.subject mouse
dc.subject nuclear magnetic resonance spectroscopy
dc.subject preclinical study
dc.subject RAW 264.7 cell line
dc.subject Animals
dc.subject Anti-Inflammatory Agents
dc.subject Antineoplastic Agents
dc.subject Biological Products
dc.subject Drug Evaluation, Preclinical
dc.subject HCT116 Cells
dc.subject HT29 Cells
dc.subject Humans
dc.subject Lipopolysaccharides
dc.subject Magnetic Resonance Spectroscopy
dc.subject Mice
dc.subject Molecular Structure
dc.subject Nitric Oxide
dc.subject RAW 264.7 Cells
dc.subject Xylariales
dc.title Anti-inflammatory and cytotoxic agents from Xylaria sp. SWUF09-62 fungus
dc.type Article
dc.rights.holder Scopus
dc.identifier.bibliograpycitation Natural Product Research. Vol 35, No.12 (2021), p.2010-2019
dc.identifier.doi 10.1080/14786419.2019.1652292


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics